<?xml version="1.0" encoding="UTF-8"?>
<p>Post-transplant lymphoproliferative disease is a potentially fatal complication following stem cell and solid organ transplantation. In EBV-na√Øve patients, the 30% to 50% who then seroconvert experience PTLD [
 <xref rid="B11-cancers-10-00197" ref-type="bibr">11</xref>,
 <xref rid="B12-cancers-10-00197" ref-type="bibr">12</xref>,
 <xref rid="B13-cancers-10-00197" ref-type="bibr">13</xref>].
</p>
